The Solutions

The AnapnoGuard solution provides the clinical staff with the tools to minimize complications while maintaining the highest standards of care in intubated and ventilated patients.

It consists of a platform of automated as well as disposable devices. 

SOLUTION

The AnapnoGuard Solution

Automated ET Tube Cuff Pressure Control

Cuff pressure management, provided by the AnapnoGuard solution, ensures tracheal sealing at the minimum cuff pressure. Appropriate sealing of the trachea, allows for positive pressure ventilation while minimizing aspiration of subglottic secretions and diminishing the likelihood of tracheal tissue injuries, such as mucosal edema, ulceration, fistula, granulomas and injuries to the vocal cords.

The AnapnoGuard solution monitors air leakage from the lungs around the airway cuff, based on continuous measurement of CO2 levels in the subglottic space, above the cuff. High levels of CO2 above the cuff indicate leakage. Therefore, if the system detects a rise in CO2 level above the cuff, it increases the cuff pressure to the minimal pressure needed to ensure tracheal sealing. If no leak is detected, the system decreases the cuff pressure over time, as long as sealing is maintained. The cuff pressure is adjusted within a pressure range that has been predetermined by the clinician.

If the AnapnoGuard AG100s control unit is not available, easy monitoring and adjustment of the ET Tube cuff pressure can be achieved with the manual digital manometer, the AG Cuffill.

Effective Evacuation of Subglottic Secretions

The AnapnoGuard solution is designed to ensure effective sealing of the trachea at minimal cuff pressure, while effectively evacuating the subglottic secretions. These functions reduce pulmonary aspiration of subglottic secretions which are known to be a significant contributor to the development of Ventilator-Associated Pneumonia (VAP) and Ventilator-Associated Respiratory Infection (VARI).

The AnapnoGuard ET Tube, comprising of three unique lumens, in conjunction with the AnapnoGuard AG100s control unit, allows simultaneous subglottic rinsing or venting and evacuation of subglottic secretions.

In clinical settings, where the AnapnoGuard AG100s control unit is not available, effective rinsing and suction of the subglottic secretions can be achieved manually with the single-use AG MASS device.

 

The AnapnoGuard solution consists of the following products:

The AnapnoGuard Endotracheal Tube

02

A New Approach to Airway Management

and Tube Design.

The AnapnoGuard Endotracheal Tube (AG ET Tube) provides an advanced solution to well-known complications related to prolonged mechanical ventilation, which prevents potential infections and injury of the trachea and vocal cords.

BENEFITS

Benefits

EFFECTIVE EVACUATION OF SECRETIONS  WITH MINIMAL LUMEN BLOCKAGE

ADVANCED SEALING PROPERTIES

DUAL SUCTION LINES

ONE VENTING/ RINSING LINE

FEATURES

Features

THIN WALLED PU CUFF

The AG ET Tube unique design comprises of three lumens: two lumens for evacuation of secretions and one lumen for leak detection, venting and rinsing. This unique design allows for effective evacuation of subglottic secretions and cuff pressure control management.

 

When connecting the AG ET Tube to the AnapnoGuard AG100s Control Unit, the combination of the venting/rinsing lumen and the two suction lumens, enables effective automated simultaneous rinsing and suction of subglottic secretions, with minimal lumen blockage.

The ET Tube cuff pressure is automatically adjusted based on continuous monitoring of CO2 levels above the cuff. This technology aims to achieve tracheal sealing at the minimal possible cuff pressure, without harming the tracheal tissue.

In addition, when connecting the AG ET Tube to the manual AG MASS or even to a standard syringe, the multiple lumens enable effective evacuation of subglottic secretions, with minimal lumen blockage.

 

The revolutionary AG ET Tube is made with a thin-walled PU cuff that is especially designed with advanced sealing properties, to allow sealing at low cuff pressure.

US FDA 510(k)   |    European CE Mark   |   China CFDA

STANDARDIZED

OF CLINICAL CARE

PERSONALIZED TREATMENT  

PATIENT SAFETY

COST SAVING